Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000661789 | SCV000784107 | pathogenic | Breast-ovarian cancer, familial, susceptibility to, 2 | 2017-12-15 | reviewed by expert panel | curation | Variant allele predicted to encode a truncated non-functional protein. |
Labcorp Genetics |
RCV001857378 | SCV002155888 | pathogenic | Hereditary breast ovarian cancer syndrome | 2023-03-31 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 52685). This variant is also known as 9048del4. This premature translational stop signal has been observed in individual(s) with breast and/or ovarian cancer (PMID: 21614564, 30702160). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln2941Leufs*34) in the BRCA2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BRCA2 are known to be pathogenic (PMID: 20104584). |
Clin |
RCV000577287 | SCV000678942 | not provided | Familial cancer of breast | no assertion provided | literature only |